Envista (NYSE:NVST – Get Free Report)‘s stock had its “hold” rating reiterated by investment analysts at Needham & Company LLC in a research note issued to investors on Thursday, Benzinga reports.
Other equities research analysts have also issued research reports about the stock. Evercore ISI increased their price objective on shares of Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and boosted their target price for the company from $16.00 to $23.00 in a research note on Thursday. Bank of America decreased their price target on shares of Envista from $22.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 8th. Stifel Nicolaus increased their price target on Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. downgraded shares of Envista from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $23.00 to $16.00 in a research note on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $20.71.
View Our Latest Analysis on Envista
Envista Trading Down 0.1 %
Envista (NYSE:NVST – Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.09 by $0.03. The firm had revenue of $601.00 million for the quarter, compared to the consensus estimate of $590.34 million. Envista had a negative net margin of 53.42% and a positive return on equity of 3.59%. The business’s revenue for the quarter was down 4.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.43 EPS. As a group, research analysts predict that Envista will post 0.69 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Envista news, CFO Eric D. Hammes purchased 24,532 shares of the stock in a transaction on Monday, August 12th. The shares were purchased at an average price of $16.33 per share, with a total value of $400,607.56. Following the acquisition, the chief financial officer now directly owns 24,532 shares in the company, valued at approximately $400,607.56. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by company insiders.
Institutional Investors Weigh In On Envista
Several hedge funds have recently added to or reduced their stakes in the company. William Blair Investment Management LLC boosted its stake in Envista by 4.0% in the first quarter. William Blair Investment Management LLC now owns 14,049 shares of the company’s stock worth $300,000 after buying an additional 538 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after purchasing an additional 726 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in Envista by 50.8% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock worth $43,000 after purchasing an additional 728 shares during the period. Victory Capital Management Inc. raised its position in Envista by 2.3% in the 2nd quarter. Victory Capital Management Inc. now owns 36,021 shares of the company’s stock worth $599,000 after purchasing an additional 800 shares during the period. Finally, Blue Trust Inc. lifted its stake in Envista by 69.7% in the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares during the last quarter.
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Recommended Stories
- Five stocks we like better than Envista
- How Investors Can Find the Best Cheap Dividend Stocks
- Battle of the Retailers: Who Comes Out on Top?
- What is a Dividend King?
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- 5 discounted opportunities for dividend growth investors
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.